Development of specific Kinase Inhibitors for the Treatment of Inflammatory diseases

被引：0
|
作者：
Neubauer, G. [1 ]
机构：
[1] Cellzome, Heidelberg, Germany
来源：
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2012年 / 62卷
关键词：
MECHANISMS; CELLS;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [31] Role of janus kinase inhibitors in the treatment of rheumatic diseases
    Krueger, K.
    [J]. INTERNIST, 2019, 60 (11): : 1215 - 1220
  • [32] Treatment of Immunological or Inflammatory Disorders with ITK Kinase Inhibitors
    Abdel-Magid, Ahmed F.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 456 - 457
  • [33] Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors
    Kim, Hyung-Ook
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (11) : 1173 - 1186
  • [34] Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors
    Hyung-Ook Kim
    [J]. Archives of Pharmacal Research, 2020, 43 : 1173 - 1186
  • [35] Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
    Li, Heng
    Zuo, Jianping
    Tang, Wei
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [36] Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges
    Rokosz, Laura L.
    Beasley, James R.
    Carroll, Carolyn Dilanni
    Lin, Tsung
    Zhao, Jiuqiao
    Appell, Kenneth C.
    Webb, Maria L.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (07) : 883 - 903
  • [37] Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory Diseases
    Sabnis, Ram W.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 769 - 770
  • [38] Development of Rho kinase inhibitors for the treatment of glaucoma
    Feng, Yangbo
    LoGrasso, Philip
    Yin, Yan
    Chen, Yen Ting
    Fang, Xingang
    Chowdhury, Sarwat
    Bannister, Thomas D.
    Weiser, Aimee
    Pocas, Jennifer
    Grant, Wayne
    Schroeter, Thomas
    Cameron, Michael D.
    Lin, Li
    Ruiz, Claudia
    Khan, Susan
    Pachori, Alok
    Inoue, Toshihiro
    Rao, Vasanth
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [39] Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research
    Kerschbaumer, Andreas
    Smolen, Josef S.
    Nash, Peter
    Doerner, Thomas
    Dougados, Maxime
    Fleischmann, Roy
    Geissler, Klaus
    McInnes, Iain B.
    Takeuchi, Tsutomu
    Trauner, Michael
    Winthrop, Kevin
    de Wit, Maarten
    Boehncke, Wolf-Henning
    Falzon, Louise
    van der Heijde, Desiree
    [J]. RMD OPEN, 2020, 6 (03):
  • [40] Correspondence on 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement'
    Banday, Aaqib Zaffar
    Jindal, Ankur Kumar
    Singh, Surjit
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05)
12345